Menlo Park, CA, United States of America

Velomedix, Inc.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 75.0

Forward Citations = 146

Loading Chart...

6 inventors (with patents filed for the assignee):

Daniel Rogers Burnett (4 out of 127 patents)

Gregory Walter Hall (3 out of 61 patents)

Amit Rajguru (2 out of 17 patents)

4. Christopher Hermanson (2 out of 14 patents)

5. Shane Mangrum (1 out of 12 patents)

6. Jared Colin Blanton (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 8672884 - Method and apparatus for peritoneal hypothermia and/or resuscitation (2014-03-18),

2. 8480648 - Automated therapy system and method (2013-07-09),

3. 8439960 - Hypothermia devices and methods (2013-05-14),

4. 8100880 - Automated therapy system and method (2012-01-24),

Company Overview

Velomedix, Inc. is a medical device company focused on developing innovative therapeutics to improve outcomes for critically ill patients. Their flagship product, the VeloSorb Rapid Infuser, is designed to rapidly warm and reinfuse blood during cardiac and vascular procedures, reducing the risk of complications and improving patient recovery times. Velomedix is committed to advancing the standard of care in critical care medicine through cutting-edge technology and clinical research.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

4 Patents

#241 in Menlo Park, CA

#14,076 in California

#60,737 in US

Menlo Park, CA, United States of America

Velomedix, Inc.

Forward Citations = 146

6 inventors:

Daniel Rogers Burnett (4 out of 127 patents)

Gregory Walter Hall (3 out of 61 patents)

Amit Rajguru (2 out of 17 patents)

4. Christopher Hermanson (2 out of 14 patents)

5. Shane Mangrum (1 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Velomedix, Inc.. Retrieved from https://idiyas.com/company/velomedix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]